Gareth Iacobucci , 2025-05-08 14:11:00
UK regulators must produce clear guidelines for the prescribing and monitoring of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss, particularly when treatment is initiated online, GP leaders have urged.Representatives at the annual UK conference of local medical committees (LMCs) in Glasgow passed a motion calling for the BMA’s General Practitioners Committee UK to push for the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Care Quality Commission (CQC) to undertake an “urgent and thorough review” of the online prescribing of GLP-1 weight loss drugs “to ensure that patient safety is not compromised.”The motion also called for “robust national protocols that clearly delineate the responsibilities of online prescribers and GPs” so that GPs are not left with the burden of monitoring and managing these drugs without adequate resources and support.Representatives also called for a public awareness campaign to educate patients about the risks associated with obtaining weight loss drugs…
Source link
GPs demand tougher regulation of online prescribing of weight loss drugs
